• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Hempacco Co. Inc.

    8/13/24 6:46:20 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $HPCO alert in real time by email
    DEFA14A 1 hpco_defa14a.htm DEFA14A hpco_defa14a.htm

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    ________________

     

    SCHEDULE 14A

    ________________

     

    Proxy Statement Pursuant to Section 14(a) of the

    Securities Exchange Act of 1934

    Filed by the Registrant

     

    ☒

    Filed by a Party other than the Registrant

     

    ☐

     

    Check the appropriate box:

    ☐

    Preliminary Proxy Statement

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐

    Definitive Proxy Statement

    ☒

    Definitive Additional Materials

    ☐

    Soliciting Material under §240.14a-12

     

    HEMPACCO CO., INC.

    (Name of Registrant as Specified in its Charter)

     

    _______________________________________________________________

    (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

     

    Payment of Filing Fee (Check the appropriate box):

    ☒

    No fee required.

     

     

    ☐

    Fee paid previously with preliminary materials.

     

     

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     

     

     

    HEMPACCO CO., INC.

     

    THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

     

    ANNUAL MEETING OF STOCKHOLDERS – OCTOBER 3, 2024 AT 10:00 A.M. PACIFIC TIME

     

     

     

     

    CONTROL ID:

     

     

     

     

    REQUEST ID:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    The undersigned stockholder of HEMPACCO CO., INC., a Nevada corporation (the “Company”), hereby acknowledges receipt of the Notice of Annual Meeting of Stockholders and Proxy Statement of the Company, each dated on or around August 12, 2024, and hereby appoints Sandro Piancone and Neville Pearson proxies and attorneys-in-fact, each with full power of substitution, on behalf and in the name of the undersigned, to represent the undersigned at the 2024 annual Meeting of Stockholders of the Company, to be held on October 3, 2024 at 10:00 a.m. (Pacific time) at 9925 Airway Road, San Diego, California, 92154, and to vote all shares of the Company that the undersigned would be entitled to vote if then and there personally present, on the matters set forth on the reverse side, and all such other business as may properly come before the meeting. You hereby revoke all proxies previously given.

     

    (CONTINUED AND TO BE SIGNED ON REVERSE SIDE.)

     

     

     

     

    VOTING INSTRUCTIONS

     

     

     

    If you vote by phone, fax or internet, please DO NOT mail your proxy card.

     

     

     

     

     

     

     

    MAIL:

    Please mark, sign, date, and return this Proxy Card promptly using the enclosed envelope.

     

     

     

    FAX:

    Complete the reverse portion of this Proxy Card and Fax to 202-521-3464.

     

     

     

    INTERNET:

    https://www.iproxydirect.com/HPCO

     

     

     

    PHONE:

    1-866-752-VOTE(8683)

     

     

     

     

     
    2

     

     

    ANNUAL MEETING OF THE STOCKHOLDERS OF HEMPACCO CO., INC.

    PLEASE COMPLETE, DATE, SIGN AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE.

    PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE: ☒

     

     

    PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

     

     

     

     

     

    Proposal 1

     

    FOR

     

    WITHHOLD

     

     

     

     

     

     

    Election of Directors

     

     

     

     

     

     

     

     

     

     

    Sandro Piancone

     

    ☐

     

    ☐

     

     

     

     

     

     

    Jorge Olson

     

    ☐

     

    ☐

     

     

    CONTROL ID:

     

     

    Jerry Halamuda

     

    ☐

     

    ☐

     

     

    REQUEST ID:

     

     

     

    Paul Glavine

     

    ☐

     

    ☐

     

     

     

     

     

     

    Harrison Newlands

     

    ☐

     

    ☐

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Proposal 2

     

    FOR

     

    AGAINST

     

    ABSTAIN

     

     

     

     

    Ratification of the appointment of dbbmckennon as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.

     

    ☐

     

    ☐

     

    ☐

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Proposal 3

     

    FOR

     

    AGAINST

     

    ABSTAIN

     

     

     

     

    To approve, by non-binding vote, the compensation of the Company’s named executives.

     

    ☐

     

    ☐

     

    ☐

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    MARK “X” HERE IF YOU PLAN TO ATTEND THE MEETING: ☐

    This Proxy, when properly executed will be voted as provided above, or if no contrary direction is indicated, it will be voted “For All” In Proposal 1 and “For” each of Proposals 2 and 3, and for all such other business as may properly come before the meeting in the sole determination of the Proxies.

     

     

     

     

     

    MARK HERE FOR ADDRESS CHANGE   ☐  New Address (if applicable):

    ____________________________

    ____________________________

    ____________________________

     

    IMPORTANT: Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.

     

    Dated: ________________________, 2024

     

     

     

    (Print Name of Stockholder and/or Joint Tenant)

     

    (Signature of Stockholder)

     

    (Second Signature if held jointly)

     

     
    3

     

     

    Get the next $HPCO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HPCO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HPCO
    Leadership Updates

    Live Leadership Updates

    See more
    • Hempacco Announces Opening of European Office as Part of International Expansion Strategy

      Jakub Duda appointed Country Manager of Hempacco EuropeSan Diego, California--(Newsfile Corp. - April 4, 2023) - Hempacco Co, Inc. (NASDAQ:HPCO) ("Hempacco"), a hemp smokables company Disrupting Tobacco's™ nearly $1 Trillion industry with hemp cigarettes, smoking paper, and alternatives to nicotine tobacco, today announced the opening of its European office as part of its international expansion strategy. Hempacco Europe, SP. Z O.O., located in Warsaw, Poland, will be the company's new European subsidiary.This follows the company's appointment of Jakub Duda as Country Manager of Hempacco Europe. Jakub is a creative Business Development Manager with over ten years of experience leading intern

      4/4/23 9:00:00 AM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    SEC Filings

    See more
    • Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      10/10/24 5:00:29 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      9/9/24 12:45:38 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      8/23/24 4:51:27 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hempacco Receives Notification of Deficiency from Nasdaq

      San Diego, California--(Newsfile Corp. - May 31, 2024) - Hempacco Co., Inc. (NASDAQ:HPCO) ("Hempacco" or the "Company"), a vertically integrated hemp manufacturing company, announced today that on May 23, 2024, it received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company has not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the "Quarterly Report").The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.

      5/31/24 4:12:00 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • New to The Street Airs Episode 572 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network, Monday, May 6, 2024, at 10:30 PM PT

      NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television production, announces airing Episode 572 on the FOX Business Network on Monday, May 6, 2024, at 10:30 PM PT. New to The Street's Episode 572 line-up features the following Five (5) Corporate interviews: 1). Labor Relations Firm - Greer Consulting, Inc.'s (GCI) interview with Jason Greer, Founder/CEO. 2). New to The Street's "Game Changers" with TV Host Ana Berry talking with Jorge Olson, Chief Marketing Officer (CMO), Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) and Brad Wyatt, Chief Executive Officer, Illumination Brands, Inc. 3). Digital Marketing- Banzai Int

      5/6/24 9:30:00 AM ET
      $BNZI
      $HPCO
      $LRHC
      Computer Software: Prepackaged Software
      Technology
      Medicinal Chemicals and Botanical Products
      Health Care
    • New to The Street and Hempacco Co., Inc. Sign Three Month Media Contract

      NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- New to The Street and Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) ("Hempacco") signed a three-month media contract. The agreement calls for the continuation of filming and broadcasting tailored interviews and streaming digital billboard aids in New York City. The contract calls for the New to the Street's TV news host to interview key corporate representatives from Hempacco Co., Inc. Each week over the next three months, New to The Street's Hempacco interviews will air on the FOX Business Network as sponsored programming. New to The Street's TV hosts will provide in-depth interviews with HPCO's management team with focused discuss

      3/28/24 9:15:00 AM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Titus Stuart W

      4 - Hempacco Co., Inc. (0001892480) (Issuer)

      5/31/23 4:24:54 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 3: New insider Titus Stuart W claimed ownership of 100,000 shares

      3 - Hempacco Co., Inc. (0001892480) (Issuer)

      5/31/23 4:24:18 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care